DICYCLOMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dicyclomine Hydrochloride, and when can generic versions of Dicyclomine Hydrochloride launch?
Dicyclomine Hydrochloride is a drug marketed by Aurobindo Pharma Usa, Corepharma, Lannett, Pioneer Pharms, Prinston Inc, Sun Pharm Industries, Twi Pharms, Watson Labs, West Ward, Am Regent, Dr Reddys, Fosun Pharma, Fresenius Kabi Usa, Hikma, Nexus, Praxgen Pharms, Renew Pharms, Slate Run Pharma, Alpharma Us Pharms, Generics, Novitium Pharma, Bionpharma, Hikma Pharms, and Rubicon. and is included in thirty-five NDAs.
The generic ingredient in DICYCLOMINE HYDROCHLORIDE is dicyclomine hydrochloride. There are four drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the dicyclomine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dicyclomine Hydrochloride
A generic version of DICYCLOMINE HYDROCHLORIDE was approved as dicyclomine hydrochloride by WATSON LABS on June 19th, 1986.
Summary for DICYCLOMINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 24 |
NDAs: | 35 |
Finished Product Suppliers / Packagers: | 50 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Patent Applications: | 997 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DICYCLOMINE HYDROCHLORIDE at DailyMed |
Pharmacology for DICYCLOMINE HYDROCHLORIDE
Drug Class | Anticholinergic |
Mechanism of Action | Cholinergic Antagonists |
Medical Subject Heading (MeSH) Categories for DICYCLOMINE HYDROCHLORIDE
US Patents and Regulatory Information for DICYCLOMINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Twi Pharms | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | TABLET;ORAL | 216782-001 | Jun 1, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Lannett | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | TABLET;ORAL | 040230-001 | Feb 26, 1999 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Labs | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | TABLET;ORAL | 084361-001 | Feb 6, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pioneer Pharms | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | TABLET;ORAL | 088585-001 | Aug 20, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |